Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation

Neuroscience

Volumn 141, Issue 2, 2006, Pages 989-998

  Puehler, W ^a   Rittner, H L ^a   Mousa, S A ^a   Brack, A ^a   Krause, H ^a   Stein, C ^a   Schafer M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ELISA; Freund's complete adjuvant; immunohistochemistry; interleukin 1 receptor antagonist; light cycler PCR; pain

Indexed keywords

FREUND ADJUVANT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; KAPPA OPIATE RECEPTOR; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION; UPREGULATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FREUND'S ADJUVANT; GANGLIA, SPINAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; MALE; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 33746294077     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.03.078     Document Type: Article

References (59)

1. Al-Bader M.D., and Al-Sarraf H.A. Housekeeping gene expression during fetal brain development in the rat-validation by semi-quantitative RT-PCR. Brain Res Dev Brain Res 156 (2005) 38-45
2. Antonijevic I., Mousa S.A., Schäfer M., and Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 15 (1995) 165-172
3. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin-1 receptor antagonist. role in biology. Annu Rev Immunol 16 (1998) 27-55
4. Arvidsson U., Riedl M., Chakrabarti S., Vulchanova L., Lee J.H., Nakano A.H., Lin X., Loh H.H., Law P.Y., Wessendorf M.W., et al. The kappa-opioid receptor is primarily postsynaptic. combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci U S A 92 (1995) 5062-5066
5. Borner C., Höllt V., and Kraus J. Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol Pharmacol 61 (2002) 800-805
6. Brack A., Rittner H.L., Younge B.R., Kaltschmidt C., Weyand C.M., and Goronzy J. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 99 (1997) 2842-2850
7. Brack A., Rittner H.L., Machelska H., Beschmann K., Sitte N., Schäfer M., and Stein C. Mobilization of opioid-containing polymorphonuclear cells by hematopoietic growth factors and influence on inflammatory pain. Anesthesiology 100 (2004) 149-157
8. Brack A., Rittner H.L., Machelska H., Leder K., Mousa S.A., Schäfer M., and Stein C. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112 (2004) 229-238
9. Copray J.C., Mantingh I., Brouwer N., Biber K., Kust B.M., Liem R.S., Huitinga I., Tilders F.J., Van Dam A.M., and Boddeke H.W. Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 118 (2001) 203-211
10. Delcroix J.D., Valletta J.S., Wu C., Hunt S.J., Kowal A.S., and Mobley W.C. NGF signaling in sensory neurons. evidence that early endosomes carry NGF retrograde signals. Neuron 39 (2003) 69-84
11. Dinarello C.A. Reduction of inflammation by decreasing production of interleukin-1 or by specific receptor antagonism. Int J Tissue React 14 (1992) 65-75
12. Dinarello C.A., Ikejima T., Warner S.J., Orencole S.F., Lonnemann G., Cannon J.G., and Libby P. Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J Immunol 139 (1987) 1902-1910
13. Donnerer J., Schuligoi R., and Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue. evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49 (1992) 693-698
14. Eisenberg S.P., Brewer M.T., Verderber E., Heimdal P., Brandhuber B.J., and Thompson R.C. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family. evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A 88 (1991) 5232-5236
15. Ferreira S.H., Cunha F.Q., Lorenzetti B.B., Michelin M.A., Perretti M., Flower R.J., and Poole S. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol 121 (1997) 883-888
16. Fukuoka H., Kawatani M., Hisamitsu T., and Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res 657 (1994) 133-140
17. Goessl C., Krause H., Müller M., Heicappell R., Schrader M., Sachsinger J., and Miller K. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60 (2000) 5941-5945
18. Greene L.A., and Kaplan D.R. Early events in neurotrophin signalling via Trk and p75 receptors. Curr Opin Neurobiol 5 (1995) 579-587
19. Hassan A.H., Ableitner A., Stein C., and Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55 (1993) 185-195
20. Horwell D. Kappa opioid analgesics. Drugs Future 13 (1988) 1061-1070
21. Jeanjean A.P., Maloteaux J.M., and Laduron P.M. IL-1 beta-like Freund's adjuvant enhances axonal transport of opiate receptors in sensory neurons. Neurosci Lett 177 (1994) 75-78
22. Jeanjean A.P., Moussaoui S.M., Maloteaux M.J., and Laduron P.M. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 68 (1995) 151-157
23. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., and Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15 (1995) 8156-8166
24. Klapproth J., Castell J., Geiger T., Andus T., and Heinrich P.C. Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo. Eur J Immunol 19 (1989) 1485-1490
25. Lewin G.R., and Mendell L.M. Nerve growth factor and nociception. Trends Neurosci 16 (1993) 353-359
26. Likar R., Koppert W., Blatnig H., Chiari F., Sittl R., Stein C., and Schäfer M. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Symptom Manage 21 (2001) 330-337
27. Machelska H., Mousa S.A., Brack A., Schopohl J.K., Rittner H.L., Schäfer M., and Stein C. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 22 (2002) 5588-5596
28. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., and Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS. an in situ hybridization study. J Comp Neurol 350 (1994) 412-438
29. Mansour A., Burke S., Pavlic R.J., Akil H., and Watson S.J. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71 (1996) 671-690
30. Mousa S.A., Zhang Q., Sitte N., Ji R., and Stein C. beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115 (2001) 71-78
31. Obreja O., Rathee P.K., Lips K.S., Distler C., and Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons. involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 16 (2002) 1497-1503
32. Pol O., Palacio J.R., and Puig M.M. The expression of delta- and kappa-opioid receptor is enhanced during intestinal inflammation in mice. J Pharmacol Exp Ther 306 (2003) 455-462
33. Porreca F., Mosberg H.I., Hurst R., Hruby V.J., and Burks T.F. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 230 (1984) 341-348
34. Puehler W., Zöllner C., Brack A., Shaqura M.A., Krause H., Schäfer M., and Stein C. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129 (2004) 473-479
35. Reimers J., Wogensen L.D., Welinder B., Hejnaes K.R., Poulsen S.S., Nilsson P., and Nerup J. The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in normal rats. Scand J Immunol 34 (1991) 597-610
36. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., and Stein C. Opioid peptide-expressing leukocytes. identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95 (2001) 500-508
37. Rittner H.L., Machelska H., and Stein C. Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 78 (2005) 1215-1222
38. Rittner H.L., and Stein C. Involvement of cytokines, chemokines and adhesion molecules in opioid analgesia. Eur J Pain 9 (2005) 109-112
39. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., and Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115 (1995) 1265-1275
40. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., and Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
41. Scroggs R.S., and Fox A.P. Multiple Ca2+ currents elicited by action potential waveforms in acutely isolated adult rat dorsal root ganglion neurons. J Neurosci 12 (1992) 1789-1801
42. Sommer C., and Kress M. Recent findings on how proinflammatory cytokines cause pain. peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 361 (2004) 184-187
43. Stein C., Millan M.J., and Herz A. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation. alterations in behavior and nociceptive thresholds. Pharmacol Biochem Behav 31 (1988) 455-451
44. Stein C., Millan M.J., Shippenberg T.S., Peter K., and Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248 (1989) 1269-1275
45. Stein C., Hassan A.H., Lehrberger K., Giefing J., and Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 342 (1993) 321-324
46. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 332 (1995) 1685-1690
47. Stockel K., Schwab M., and Thoenen H. Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res 99 (1975) 1-16
48. Sung B., Loh H.H., and Wei L. Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury. Lett Neurosci 291 (2000) 163-166
49. Swett J.E., Torigoe Y., Elie V.R., Bourassa C.M., and Miller P.G. Sensory neurons of the rat sciatic nerve. Exp Neurol 114 (1991) 82-103
50. Tempel A., and Zukin R.S. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci U S A 84 (1987) 4308-4312
51. Tsai T.H., Chen S.L., Xiao X., Chiang Y.H., Lin S.Z., Kuo S.W., Liu D.W., and Tsao Y.P. Gene treatment of cerebral stroke by rAAV vector delivering IL-1ra in a rat model. Neuroreport 14 (2003) 803-807
52. Van Zee K.J., Coyle S.M., Calvano S.E., Oldenburg H.S., Stiles D.M., Pribble J., Catalano M., Moldawer L.L., and Lowry S.F. Influence of IL-1 receptor blockade on the human response to endotoxemia. J Immunol 154 (1995) 1499-1507
53. Walker J.S. Anti-inflammatory effects of opioids. Adv Exp Med Biol 521 (2003) 148-160
54. White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D.N., Lamotte R.H., and Miller R.J. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 102 (2005) 14092-14097
55. Wilson J.L., Nayanar V., and Walker J.S. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis. importance of local administration. Br J Pharmacol 118 (1996) 1754-1760
56. Woolf C.J., Allchorne A., Safieh-Garabedian B., and Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia. the contribution of tumour necrosis factor alpha. Br J Pharmacol 121 (1997) 417-424
57. Zhang Q., Schäfer M., Elde R., and Stein C. Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 85 (1998) 281-291
58. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110
59. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S., Stein C., and Schäfer M. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64 (2003) 202-210